Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
Ashitaba seems to improve glucose intolerance and decrease triglyceride (TG) and total cholesterol (TC), which contribute to the development of non-alcoholic fatty liver disease (NAFLD). However, it remains to be explored the mechanism of Ashitaba in managing NAFLD. We determined the impact of Ashit...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2023-10-01
|
| Col·lecció: | Frontiers in Medicine |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1247851/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|